Technical Analysis for GNCA - Genocea Biosciences, Inc.

Grade Last Price % Change Price Change
grade F 3.06 -5.56% -0.18
GNCA closed down 5.56 percent on Friday, August 23, 2019, on 25 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GNCA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.56%
20 DMA Support Bullish -5.56%
Narrow Range Bar Range Contraction -5.56%
NR7 Range Contraction -5.56%
Inside Day Range Contraction -5.56%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.42%
Crossed Above 20 DMA Bullish -6.42%
Pocket Pivot Bullish Swing Setup -6.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.16%

Older signals for GNCA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Genocea Biosciences, Inc., a clinical stage biotechnology company, discovers and develops novel vaccines to treat infectious diseases. The company, through its proprietary discovery platform, AnTigen Lead Acquisition System (ATLAS), designs vaccines that stimulate T cell immunity. The company primarily develops GEN-003, a candidate therapeutic vaccine or immunotherapy, which is in Phase 1/2a trial to treat herpes simplex virus-2 or HSV-2 infections; and GEN-004, a T cell vaccine candidate that is in Phase 1 trial to prevent infections caused by pneumococcus. It also develops earlier-stage programs for chlamydia, HSV-2 prophylaxis, and malaria. The company, formerly known as Genocea, Inc., was founded in 2006 and is headquartered in Cambridge, Massachusetts.
Biotechnology Medical Specialties Infectious Diseases Immunotherapy Vaccination Microbiology Infections Vaccine Herpes Simplex Virus Malaria Herpes Simplex Sexually Transmitted Diseases And Infections Herpes Simplex Research Viruses
Is GNCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.28
52 Week Low 2.24
Average Volume 377,904
200-Day Moving Average 4.6391
50-Day Moving Average 3.6163
20-Day Moving Average 3.2025
10-Day Moving Average 3.125
Average True Range 0.2402
ADX 12.81
+DI 17.4426
-DI 19.8518
Chandelier Exit (Long, 3 ATRs ) 3.0694
Chandelier Exit (Short, 3 ATRs ) 3.6313
Upper Bollinger Band 3.5106
Lower Bollinger Band 2.8944
Percent B (%b) 0.27
BandWidth 19.241218
MACD Line -0.1569
MACD Signal Line -0.1957
MACD Histogram 0.0388
Fundamentals Value
Market Cap 87.6 Million
Num Shares 28.6 Million
EPS -2.04
Price-to-Earnings (P/E) Ratio -1.50
Price-to-Sales 0.00
Price-to-Book 1.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.53
Resistance 3 (R3) 3.55 3.42 3.45
Resistance 2 (R2) 3.42 3.30 3.41 3.42
Resistance 1 (R1) 3.24 3.23 3.18 3.22 3.40
Pivot Point 3.11 3.11 3.08 3.10 3.11
Support 1 (S1) 2.93 2.99 2.86 2.90 2.72
Support 2 (S2) 2.80 2.92 2.79 2.70
Support 3 (S3) 2.62 2.80 2.67
Support 4 (S4) 2.59